FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011832012> ?p ?o ?g. }

• W2011832012 endingPage "485" @default.
• W2011832012 startingPage "480" @default.
• W2011832012 abstract "Background The recommended second-line therapy for Helicobacter pylori (H. pylori) eradication is a quadruple regimen that fails in up to 30% of patients. Several recent studies suggest levofloxacin-based triple therapies as an alternative rescue treatment. However, dosage and length of levofloxacin-based regimens have not been established. Aim To compare the efficacy and tolerability of four second-line levofloxacin-based schemes for H. pylori eradication. Methods One hundred and sixty patients (aged 18–70 years, 72 male patients) who were H. pylori positive after standard triple therapies were randomised to receive esomeprazole 20 mg b.d. and amoxicillin 1 g b.d. plus levofloxacin 500 mg o.d., for 7 or 10 days (Groups A and B) or levofloxacin 500 mg b.d. for 7 days or 10 days (Groups C and D). H. pylori status was assessed by 13-C Urea Breath Test or rapid urease test, before and 6 weeks after therapy. Incidence of side effects was evaluated by a questionnaire. Results No dropouts were observed. Eradication of H. pylori infection was successful in: 65% of patients in Group A; 90% in Group B; 70% in Group C; 85% in Group D. Based upon duration of treatment, eradication rates were: 67.5% in 7 days groups and 87.5% in 10 days groups (p = 0.004). Dosage of levofloxacin did not affect the eradication rates (77.5% both in the once daily and twice daily groups). Mild adverse events were reported overall in 16% of patients (22.5% in 7 days groups; 27.5% in 10 days groups; p = 0.58; 12% in the once daily group; 32.5% in the twice daily group; p = 0.04). Conclusions 10 days levofloxacin-based second-line regimens were effective in curing H. pylori infection in more than 85% of patients with a lower incidence of adverse effects in levofloxacin single-dosage scheme. The 10 days levofloxacin-based regimens were more effective than 7 days course of treatment showing that duration of therapy is the crucial factor affecting eradication rate." @default.
• W2011832012 created "2016-06-24" @default.
• W2011832012 creator A5010727473 @default.
• W2011832012 creator A5012828437 @default.
• W2011832012 creator A5018156263 @default.
• W2011832012 creator A5027389700 @default.
• W2011832012 creator A5052785604 @default.
• W2011832012 creator A5078126497 @default.
• W2011832012 creator A5080637224 @default.
• W2011832012 creator A5082215345 @default.
• W2011832012 creator A5083163170 @default.
• W2011832012 date "2009-07-01" @default.
• W2011832012 modified "2023-10-17" @default.
• W2011832012 title "Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication" @default.
• W2011832012 cites W1552362143 @default.
• W2011832012 cites W1563355546 @default.
• W2011832012 cites W1796575397 @default.
• W2011832012 cites W1797829304 @default.
• W2011832012 cites W1966243555 @default.
• W2011832012 cites W1969507965 @default.
• W2011832012 cites W1972911832 @default.
• W2011832012 cites W1974662372 @default.
• W2011832012 cites W1981314660 @default.
• W2011832012 cites W1983225539 @default.
• W2011832012 cites W1984316482 @default.
• W2011832012 cites W1987823619 @default.
• W2011832012 cites W1989413302 @default.
• W2011832012 cites W2003405710 @default.
• W2011832012 cites W2007139524 @default.
• W2011832012 cites W2008635223 @default.
• W2011832012 cites W2012160272 @default.
• W2011832012 cites W2019215575 @default.
• W2011832012 cites W2030304316 @default.
• W2011832012 cites W2037279675 @default.
• W2011832012 cites W2040436022 @default.
• W2011832012 cites W2060551278 @default.
• W2011832012 cites W2061938579 @default.
• W2011832012 cites W2066886904 @default.
• W2011832012 cites W2079175995 @default.
• W2011832012 cites W2081721924 @default.
• W2011832012 cites W2095226690 @default.
• W2011832012 cites W2101730203 @default.
• W2011832012 cites W2106683700 @default.
• W2011832012 cites W2123569089 @default.
• W2011832012 cites W2124176837 @default.
• W2011832012 cites W2134155826 @default.
• W2011832012 cites W2147374743 @default.
• W2011832012 cites W2154994164 @default.
• W2011832012 cites W2159156126 @default.
• W2011832012 cites W2184270330 @default.
• W2011832012 doi "https://doi.org/10.1016/j.dld.2008.09.013" @default.
• W2011832012 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18974025" @default.
• W2011832012 hasPublicationYear "2009" @default.
• W2011832012 type Work @default.
• W2011832012 sameAs 2011832012 @default.
• W2011832012 citedByCount "53" @default.
• W2011832012 countsByYear W20118320122012 @default.
• W2011832012 countsByYear W20118320122013 @default.
• W2011832012 countsByYear W20118320122014 @default.
• W2011832012 countsByYear W20118320122015 @default.
• W2011832012 countsByYear W20118320122016 @default.
• W2011832012 countsByYear W20118320122017 @default.
• W2011832012 countsByYear W20118320122018 @default.
• W2011832012 countsByYear W20118320122020 @default.
• W2011832012 countsByYear W20118320122021 @default.
• W2011832012 countsByYear W20118320122022 @default.
• W2011832012 crossrefType "journal-article" @default.
• W2011832012 hasAuthorship W2011832012A5010727473 @default.
• W2011832012 hasAuthorship W2011832012A5012828437 @default.
• W2011832012 hasAuthorship W2011832012A5018156263 @default.
• W2011832012 hasAuthorship W2011832012A5027389700 @default.
• W2011832012 hasAuthorship W2011832012A5052785604 @default.
• W2011832012 hasAuthorship W2011832012A5078126497 @default.
• W2011832012 hasAuthorship W2011832012A5080637224 @default.
• W2011832012 hasAuthorship W2011832012A5082215345 @default.
• W2011832012 hasAuthorship W2011832012A5083163170 @default.
• W2011832012 hasConcept C120665830 @default.
• W2011832012 hasConcept C121332964 @default.
• W2011832012 hasConcept C126322002 @default.
• W2011832012 hasConcept C197934379 @default.
• W2011832012 hasConcept C2775981797 @default.
• W2011832012 hasConcept C2776409635 @default.
• W2011832012 hasConcept C2777172195 @default.
• W2011832012 hasConcept C2777785397 @default.
• W2011832012 hasConcept C2778204628 @default.
• W2011832012 hasConcept C2778375690 @default.
• W2011832012 hasConcept C2779708577 @default.
• W2011832012 hasConcept C2780678043 @default.
• W2011832012 hasConcept C2780708398 @default.
• W2011832012 hasConcept C2781276175 @default.
• W2011832012 hasConcept C2781413609 @default.
• W2011832012 hasConcept C2908868296 @default.
• W2011832012 hasConcept C501593827 @default.
• W2011832012 hasConcept C61511704 @default.
• W2011832012 hasConcept C71924100 @default.
• W2011832012 hasConcept C86803240 @default.
• W2011832012 hasConcept C89423630 @default.
• W2011832012 hasConcept C90924648 @default.

• next